Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOXB7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PSMD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PINK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP85 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC26A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLYWCH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PBDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZSCAN18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2Z - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZER1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AAED1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on